2017 Q3 Form 10-K Financial Statement

#000143774917016410 Filed on September 28, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2017 2016 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $510.0K $2.020M $310.0K
YoY Change 142.86% 42.25% 82.35%
% of Gross Profit
Research & Development $290.0K $1.840M $210.0K
YoY Change -6.45% 127.16% 2000.0%
% of Gross Profit
Depreciation & Amortization $1.748K $21.91K $11.00K
YoY Change -84.11% -61.29% 10.01%
% of Gross Profit
Operating Expenses $780.6K $3.979M $530.0K
YoY Change 33.84% 65.19% 178.95%
Operating Profit -$780.6K -$3.979M
YoY Change 33.84% 65.19%
Interest Expense $30.00K $160.0K
YoY Change -400.0% -46.67%
% of Operating Profit
Other Income/Expense, Net $0.00 -$130.0K $0.00
YoY Change -100.0% -100.0%
Pretax Income -$780.0K -$4.000M -$300.0K
YoY Change 34.48% 145.4% 275.0%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$780.6K -$3.999M -$301.0K
YoY Change 39.47% 144.8% 276.19%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.02 -$89.25K -$0.01
COMMON SHARES
Basic Shares Outstanding 461.0M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q3 2017 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.380M $1.960M $540.0K
YoY Change -70.26% 262.96% -31.65%
Cash & Equivalents $1.377M $1.960M $544.8K
Short-Term Investments $0.00
Other Short-Term Assets $40.00K $40.00K $10.00K
YoY Change 0.0% 300.0% -50.0%
Inventory
Prepaid Expenses $37.00K $11.55K
Receivables $130.8K $40.00K $13.96K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.545M $2.040M $570.3K
YoY Change -67.12% 257.89% -38.68%
LONG-TERM ASSETS
Property, Plant & Equipment $26.06K $30.00K $21.91K
YoY Change 138.84% 50.0% -72.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $26.06K $30.00K $21.91K
YoY Change 160.57% 50.0% -72.61%
TOTAL ASSETS
Total Short-Term Assets $1.545M $2.040M $570.3K
Total Long-Term Assets $26.06K $30.00K $21.91K
Total Assets $1.571M $2.070M $592.2K
YoY Change -66.64% 250.85% -41.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $192.5K $160.0K $215.4K
YoY Change 28.36% -27.27% 115.39%
Accrued Expenses $202.9K $70.00K $24.74K
YoY Change 914.27% 250.0% -91.16%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $590.0K $410.0K $530.0K
YoY Change 43.9% -22.64% -62.41%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $590.0K $410.0K $530.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $585.8K $410.0K $533.9K
YoY Change 42.88% -22.64% -62.13%
SHAREHOLDERS EQUITY
Retained Earnings -$98.74M -$93.96M
YoY Change
Common Stock $462.5K $364.9K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $985.4K $1.660M $58.30K
YoY Change
Total Liabilities & Shareholders Equity $1.571M $2.070M $592.2K
YoY Change -66.64% 250.85% -41.36%

Cashflow Statement

Concept 2017 Q3 2017 2016 Q2
OPERATING ACTIVITIES
Net Income -$780.6K -$3.999M -$301.0K
YoY Change 39.47% 144.8% 276.19%
Depreciation, Depletion And Amortization $1.748K $21.91K $11.00K
YoY Change -84.11% -61.29% 10.01%
Cash From Operating Activities -$587.6K -$3.360M -$520.0K
YoY Change -17.26% 61.54% -66.01%
INVESTING ACTIVITIES
Capital Expenditures -$30.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$30.00K $0.00
YoY Change -137.5% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $5.178M
YoY Change -100.0% 185.28%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.810M 820.0K
YoY Change 173.3% -49.69%
NET CHANGE
Cash From Operating Activities -587.6K -3.360M -520.0K
Cash From Investing Activities -30.00K 0.000
Cash From Financing Activities 4.810M 820.0K
Net Change In Cash -587.6K 1.420M 300.0K
YoY Change -114.34% -691.67% 400.0%
FREE CASH FLOW
Cash From Operating Activities -$587.6K -$3.360M -$520.0K
Capital Expenditures -$30.00K
Free Cash Flow -$3.330M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017 nsrc Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Expired
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired
0.14
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
CY2017 dei Document Type
DocumentType
10-K
CY2016Q4 dei Entity Public Float
EntityPublicFloat
22995535
CY2016 nsrc Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised
CY2017 nsrc Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised
CY2016 nsrc Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Expired
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired
0.12
CY2017 dei Entity Central Index Key
EntityCentralIndexKey
0001302084
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
460995711
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017 dei Entity Registrant Name
EntityRegistrantName
NextSource Materials Inc.
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2017 dei Trading Symbol
TradingSymbol
nsrc
CY2017 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2014Q1 nsrc Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssued
0.18
CY2016 nsrc Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssued
0.11
CY2017 nsrc Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssued
CY2016 nsrc Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
20550998
CY2017 nsrc Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
CY2016 nsrc Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
4846744
CY2017 nsrc Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
34721175
CY2016 nsrc Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
27021256
CY2017 nsrc Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
CY2017Q2 nsrc Contingency Provision
ContingencyProvision
182883
CY2016Q2 nsrc Contingency Provision
ContingencyProvision
182742
CY2016 nsrc Conversion Of Special Warrants Into Common Shares Amount
ConversionOfSpecialWarrantsIntoCommonSharesAmount
CY2015Q3 nsrc Conversion Of Special Warrants Into Common Shares Shares
ConversionOfSpecialWarrantsIntoCommonSharesShares
20550998
CY2017 nsrc Income Tax Rate Reconciliation Change In Enacted Tax Rate And Other Adjustments Amount
IncomeTaxRateReconciliationChangeInEnactedTaxRateAndOtherAdjustmentsAmount
-147580
CY2016 nsrc Income Tax Rate Reconciliation Change In Enacted Tax Rate And Other Adjustments Amount
IncomeTaxRateReconciliationChangeInEnactedTaxRateAndOtherAdjustmentsAmount
-703720
CY2017 nsrc Income Tax Rate Reconciliation Nondeductible Expense Benefit Amount
IncomeTaxRateReconciliationNondeductibleExpenseBenefitAmount
8830
CY2016 nsrc Income Tax Rate Reconciliation Nondeductible Expense Benefit Amount
IncomeTaxRateReconciliationNondeductibleExpenseBenefitAmount
-255860
CY2014 nsrc Number Of Flowthrough Shares Issued To Eligible Canadian Taxpayer Subscribers
NumberOfFlowthroughSharesIssuedToEligibleCanadianTaxpayerSubscribers
17889215
CY2017Q2 nsrc Operating Loss Carryforwards Next Twelve Months
OperatingLossCarryforwardsNextTwelveMonths
4130
CY2017Q2 nsrc Operating Loss Carryforwards Year Eight
OperatingLossCarryforwardsYearEight
5264970
CY2017Q2 nsrc Operating Loss Carryforwards Year Eleven
OperatingLossCarryforwardsYearEleven
4880240
CY2017Q2 nsrc Operating Loss Carryforwards Year Five
OperatingLossCarryforwardsYearFive
341250
CY2017Q2 nsrc Operating Loss Carryforwards Year Four
OperatingLossCarryforwardsYearFour
909180
CY2017Q2 nsrc Operating Loss Carryforwards Year Nine
OperatingLossCarryforwardsYearNine
4956930
CY2017Q2 nsrc Operating Loss Carryforwards Year Seven
OperatingLossCarryforwardsYearSeven
3998670
CY2017Q2 nsrc Operating Loss Carryforwards Year Six
OperatingLossCarryforwardsYearSix
3435600
CY2017Q2 nsrc Operating Loss Carryforwards Year Ten
OperatingLossCarryforwardsYearTen
3642800
CY2017Q2 nsrc Operating Loss Carryforwards Year Thirteen
OperatingLossCarryforwardsYearThirteen
4978979
CY2017Q2 nsrc Operating Loss Carryforwards Year Three
OperatingLossCarryforwardsYearThree
283870
CY2017Q2 nsrc Operating Loss Carryforwards Year Twelve
OperatingLossCarryforwardsYearTwelve
4549970
CY2017Q2 nsrc Operating Loss Carryforwards Year Two
OperatingLossCarryforwardsYearTwo
29460
CY2017 nsrc Warrant Term
WarrantTerm
P292D
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
331491
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
794864
CY2015Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.10
CY2016Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.13
CY2016 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
51557
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
159147
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
215391
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39441
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13955
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
68241
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24743
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
117048
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
173650
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
CY2017 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
195561
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
99160128
CY2016Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
93654114
CY2017 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
370671
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
74991256
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
107207431
CY2017Q2 us-gaap Assets
Assets
2071290
CY2016Q2 us-gaap Assets
Assets
592224
CY2017Q2 us-gaap Assets Current
AssetsCurrent
2043485
CY2016Q2 us-gaap Assets Current
AssetsCurrent
570313
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1964948
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
544813
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
779118
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1420135
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-234305
CY2017Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.11
CY2017Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20126511
CY2016Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
18858170
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1629390
CY2017Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
30521256
CY2016Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
65242431
CY2015Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
63618917
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
650000000
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
650000000
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
460995711
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
364931425
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
460995711
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
364931425
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
460996
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
364932
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3999358
CY2017Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
20126511
CY2016Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
18858170
CY2017Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2016Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2017Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
7041230
CY2016Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
7562070
CY2017Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
6890
CY2016Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
6890
CY2017Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
31780
CY2016Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
29230
CY2017Q2 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
13046610
CY2016Q2 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
11259980
CY2017 us-gaap Depreciation
Depreciation
21911
CY2016 us-gaap Depreciation
Depreciation
56602
CY2016 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
623
CY2017Q2 us-gaap Liabilities
Liabilities
410271
CY2017Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
CY2016Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
111049
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2017 us-gaap Exploration Expense Mining
ExplorationExpenseMining
1839659
CY2016 us-gaap Exploration Expense Mining
ExplorationExpenseMining
812477
CY2017 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-111049
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-733802
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
458780
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
279097
CY2017 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-93476
CY2016 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-106036
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
59556
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1260325
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1415360
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1399775
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-571800
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
278200
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
116020
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-12746
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-139398
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
53037
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-40016
CY2017 us-gaap Interest Expense
InterestExpense
CY2016 us-gaap Interest Expense
InterestExpense
11371
CY2017 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
CY2016Q2 us-gaap Liabilities
Liabilities
533925
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2071290
CY2017Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
37276037
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
592224
CY2017 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
141
CY2016 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
-7345
CY2017 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
CY2016 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
-8068
CY2017 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
CY2016 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-18916
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4807214
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1763456
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-27805
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
80320
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3359274
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2078081
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-3999358
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-1633713
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017 us-gaap Operating Expenses
OperatingExpenses
3979087
CY2016 us-gaap Operating Expenses
OperatingExpenses
2408778
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-3979087
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-2408778
CY2017 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-4323
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3745
CY2017 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
21911
CY2016 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
56602
CY2017 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
131320
CY2016 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
CY2017 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
370671
CY2016 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
51557
CY2017 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
27805
CY2016 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
0
CY2017Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
39096
CY2016Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11545
CY2017 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
CY2016 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
11371
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5177885
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1815013
CY2017 us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
CY2016 us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
76450
CY2017 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
CY2016 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3870
CY2017 us-gaap Professional Fees
ProfessionalFees
770397
CY2016 us-gaap Professional Fees
ProfessionalFees
811704
CY2017 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
27805
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27805
CY2017 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
195561
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
195561
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
195561
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78513
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21911
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27805
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.18
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97960105
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-93960747
CY2017 us-gaap Revenues
Revenues
0
CY2016 us-gaap Revenues
Revenues
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
35365000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.11
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.07
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.22
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
794864
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
331491
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.82
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.91
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0111
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0074
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
46000000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1900000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
18635000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
21140000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
8500000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
8500000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
21140000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
44470000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
41965000
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.23
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.23
CY2015Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.06
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.06
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.07
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
794864
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
331491
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P3Y182D
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5177885
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
1661019
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
58299
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
-407258
CY2017Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">The preparation of these <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of these consolidated financial statements and the reported amounts of revenues and expenses during the period. On an ongoing basis, management evaluates its judgments and estimates in relation to assets, liabilities, revenue and expenses. Management uses past experience and other factors as the basis for its judgments and estimates. Actual results <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>differ from those estimates. The impacts of estimates are pervasive throughout these consolidated financial statements and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>require accounting adjustments based on future occurrences. Revisions to accounting estimates are recognized in the period in which the estimate is revised and the revision affects current and future periods. Areas where significant estimates and assumptions are used include: the binomial valuation of the warrant liability, the Black-Scholes valuation of warrants and stock options, the valuation recorded for future income taxes and the assumption that the Company will receive title to the properties after the Madagascar political situation stabilizes.</div></div></div></div></div></div></div></div></div></div>
CY2016Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
111049
CY2015Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
844851
CY2017Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
448187140
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
343243652

Files In Submission

Name View Source Status
0001437749-17-016410-index-headers.html Edgar Link pending
0001437749-17-016410-index.html Edgar Link pending
0001437749-17-016410.txt Edgar Link pending
0001437749-17-016410-xbrl.zip Edgar Link pending
a1.jpg Edgar Link pending
a2.jpg Edgar Link pending
a3.jpg Edgar Link pending
ex_95763.htm Edgar Link pending
ex_95764.htm Edgar Link pending
ex_95765.htm Edgar Link pending
ex_95766.htm Edgar Link pending
ex_95767.htm Edgar Link pending
ex_95886.htm Edgar Link pending
ex_95887.htm Edgar Link pending
ex_95888.htm Edgar Link pending
ex_95889.htm Edgar Link pending
ex_95890.htm Edgar Link pending
ex_95891.htm Edgar Link pending
ex_95892.htm Edgar Link pending
ex_95893.htm Edgar Link pending
ex_95894.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
logo.jpg Edgar Link pending
nsrc-20170630.xml Edgar Link completed
nsrc-20170630.xsd Edgar Link pending
nsrc-20170630_cal.xml Edgar Link unprocessable
nsrc-20170630_def.xml Edgar Link unprocessable
nsrc-20170630_lab.xml Edgar Link unprocessable
nsrc-20170630_pre.xml Edgar Link unprocessable
nsrc20170630_10k.htm Edgar Link pending
nsrc20170630_10kimg002.jpg Edgar Link pending
nsrc20170630_10kimg003.jpg Edgar Link pending
nsrc20170630_10kimg004.jpg Edgar Link pending
nsrc20170630_10kimg005.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending